UNSPSC 51143221: Nicotine tartrate

This classification denotes a nicotinic agonist and alkaloid with the molecular formula C10H14N2.2C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7892ZN5G41, chemically known as pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (s)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (9ci) but more generally known as nicotine tartrate, which bears US NIH Compound Identifier 6174. European Medicines Agency schedules Nicotine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22391.

Most nations, for tariff and trade purposes, schedule nicotine tartrate under HS 29399990. SMILES: CN1CCC[C@H]1C2CCCNC2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51143221 Nicotine tartrate is a Commodity code representing a narrow chemical input used in pharmaceutical and therapeutic manufacturing. State and local procurement activity under this code shows minimal direct purchasing; the recent opportunities posted under it do not involve nicotine tartrate itself but instead reflect pharmaceutical and health-service procurement that is miscoded or tagged broadly. Seminole County, Florida (IFB 60459723LAS, due July 26, 2023) solicited naloxone and safe drug deactivation systems through competitive bidding, and the Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) issued an exploratory request for information on direct-to-manufacturer prescription programs. Neither solicitation targets nicotine tartrate as a commodity input. State and local governments that do procure pharmaceutical precursors or therapeutic chemical inputs do so infrequently and typically through health departments, university research facilities, or specialized treatment programs; the code itself does not appear to be an active procurement category in current state and local markets.

The geographic spread of coded activity is limited to two jurisdictions with recent posts — Florida and Texas — and both opportunities are tangential to the code's nominal scope. The Seminole County opportunity reflects narcotics-reversal and drug-disposal procurement driven by community health initiative funding, while the Texas HHS Commission's RFI explores wholesale prescription fulfillment models rather than chemical commodities. No recent opportunities demonstrate active demand for nicotine tartrate itself at the state or local level. This code shows little relevant recent activity and appears to be a poor fit for business development focus in state and local procurement unless your firm supplies pharmaceutical precursors to research institutions, poison-control centers, or smoking-cessation programs operating under state or county health agency contracts — a narrow and infrequent procurement lane.